Crescent Biopharma (CBIO) Leases (2020 - 2025)
Crescent Biopharma (CBIO) has disclosed Leases for 6 consecutive years, with $1.5 million as the latest value for Q4 2025.
- Quarterly Leases changed N/A to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.5 million for FY2025, N/A changed from the prior year.
- Leases for Q4 2025 was $1.5 million at Crescent Biopharma, down from $1.6 million in the prior quarter.
- The five-year high for Leases was $2.1 million in Q1 2021, with the low at $424209.0 in Q2 2024.
- Average Leases over 5 years is $1.2 million, with a median of $1.2 million recorded in 2023.
- The sharpest move saw Leases tumbled 64.13% in 2024, then surged 278.82% in 2025.
- Over 5 years, Leases stood at $1.6 million in 2021, then plummeted by 52.34% to $751174.0 in 2022, then grew by 2.22% to $767828.0 in 2023, then tumbled by 44.75% to $424209.0 in 2024, then soared by 246.29% to $1.5 million in 2025.
- According to Business Quant data, Leases over the past three periods came in at $1.5 million, $1.6 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.